labtest.bio

What labtest.bio does

Labtest Bio, operating under the legal entity Pro-Lab Diagnostics, is a US-based molecular diagnostic reference laboratory specializing in Nucleic Acid Amplification Test (NAAT) based infectious disease testing. The company operates three primary processing sites — Georgetown TX, Irvine CA, and Princeton NJ — plus a Round Rock TX data center, providing nationwide next-day turnaround. Its core chemistry platform is the proprietary ProAmpHT Isothermal Amplification technology, supplemented by PCR, supporting a customizable menu of approximately 10 diagnostic panels tailored to specific clinical indications.

The company sells primarily B2B into healthcare provider segments including OBGYN practices, skilled nursing facilities (SNFs), and urgent care clinics, using a sales-led go-to-market motion. As a differentiator, Labtest Bio offers its Pro LIMS electronic medical record (EMR) integration at no cost, embedding test ordering and result delivery into customer clinical workflows. The lab is credentialed under CLIA, COLA, and ISO 13485:2016, qualifying it to serve institutional and government-payor work and signaling adherence to high-complexity testing standards.

Labtest Bio's revenue mechanics follow a per-test reference laboratory model with no public pricing disclosed. The company is privately held, reports no funding rounds or M&A activity in available data, and operates with an 11–50 employee base that includes PhD-level lab directors and Medical Laboratory Scientist certified staff. Strategic product activity over 2021–2022 included COVID-19 variant detection validation (December 2021) and a customized C. difficile panel launch (December 2022), indicating active menu expansion beyond pandemic-era respiratory testing.

Name

labtest.bio

Legal name

Pro-Lab Diagnostics

Website

https://labtest.bio

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Labtest Bio is a US molecular diagnostic reference laboratory offering customizable NAAT-based infectious disease testing panels with next-day turnaround for healthcare providers including OBGYNs, skilled nursing facilities, and urgent care clinics.

Ownership category

akta.pro rank

Product category

Molecular Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Reference & Esoteric Testing Laboratories (HLAFAMAJ), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Molecular diagnostic testing
• Clinical reference laboratory
• NAAT pathogen detection
• Infectious disease testing
• Antimicrobial resistance testing

Headquarters

HQ city

Georgetown

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostic Testing Services: Core revenue from molecular diagnostic laboratory testing services delivered to healthcare providers. Tests include customizable panels for infectious diseases, antibiotic resistance profiling, and confirmatory testing. Revenue is generated per test, with next-day turnaround and free sample pickup logistics.
2. Affordable Cash Pay / Patient Payment Portal: Direct patient billing through a dedicated patient payment portal offering transparent pricing and dispute resolution for uninsured or out-of-pocket patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Labtest Bio is a national molecular reference laboratory that delivers customizable NAAT (Nucleic Acid Amplification Test) diagnostic panels — covering UTIs, C. difficile, respiratory infections, GI infections, wound infections, vaginitis, candidiasis, nail fungus, STIs, and antibiotic resistance — to healthcare providers. Powered by proprietary ProAmpHT isothermal amplification technology and supported by free Pro LIMS EMR integration, the lab provides next-morning (24-hour) results with same-day sample pickup.

Product overview

Labtest Bio is a National Molecular Reference Laboratory providing a complete and dedicated NAAT (Nucleic Acid Amplification Test) program. The core offering consists of state-of-the-art molecular diagnostic panels powered by the proprietary ProAmpHT Isothermal Amplification Technology, delivering next-day results. The company offers ten customizable diagnostic panels: Candidiasis, Vaginitis/Vaginosis, C. difficile, UTI, Wound Infection, Antibiotic Resistance, Gastrointestinal (GI), Respiratory Pathogen (RPP), Nail Fungus, and STI panels. These panels are supported by the Pro LIMS lab software platform featuring free EMR integration. The company operates three strategically located facilities nationwide (Texas, California, New Jersey) and emphasizes rapid turnaround times with next-morning results.

Differentiator

Problem solved

Functional benefit

Products and services

• Candidiasis Panel Customizable molecular diagnostic panel targeting Candida species including C. albicans, C. dubliniensis, C. glabrata, C. parapsilosis, C. tropicalis, C. lusitaniae, and C. krusei, intended for clinicians diagnosing yeast infections.
• Vaginitis/Vaginosis Panel Customizable panel targeting vaginal pathogens including Gardnerella vaginalis, Lactobacillus species, and other bacteria associated with bacterial vaginosis, intended for OBGYN and women's health providers.
• C. difficile Panel Molecular test panel detecting C. difficile Toxin A and Toxin B with 24-hour turnaround for rapid diagnosis of C. diff infection, intended for clinicians managing infectious diarrhea.
• UTI Panel Customizable urinary tract infection panel with basic targets (Acinetobacter, Candida, E. coli, Enterococcus, Klebsiella, Proteus, Pseudomonas, Staphylococcus, Streptococcus) and extended targets including additional pathogens, intended for urgent care and primary care clinicians.
• Wound Infection Panel Customizable panel targeting wound infection pathogens including Bacteroides, Staphylococcus epidermidis, Clostridium, Finegoldia magna, and other wound-associated organisms, intended for clinicians managing chronic or acute wound infections.
• Antibiotic Resistance Panel Molecular panel detecting resistance genes including beta-lactam resistance (CTX-M, IMP, KPC, NDM, OXA-48, VIM), methicillin resistance (mecA, mecC), and vancomycin resistance (vanA, vanB), intended to support antimicrobial stewardship for clinicians and pharmacists.
• Gastrointestinal (GI) Panel Comprehensive GI pathogen panel detecting Campylobacter, Listeria, Salmonella, Shigella, Cryptosporidium, Giardia, Norovirus, Rotavirus, Adenovirus, and parasites, intended for clinicians diagnosing infectious gastroenteritis.
• Respiratory Pathogen Panel (RPP) Comprehensive respiratory panel detecting viral pathogens (Influenza, RSV, Coronavirus, Rhinovirus, Adenovirus, Parainfluenza, Metapneumovirus), bacterial pathogens (Bordetella, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella), and fungi, intended for clinicians diagnosing respiratory infections.
• Nail Fungus Panel Molecular diagnostic panel targeting dermatophytes and fungi causing nail infections including Trichophyton rubrum, Aspergillus, Candida, Microsporum, and Epidermophyton, intended for dermatology and podiatry clinicians.
• STI Panel Sexually transmitted infection panel detecting Chlamydia, Neisseria gonorrhoeae, Trichomonas, Treponema pallidum, Ureaplasma, and herpesviruses (HSV-1, HSV-2, VZV, CMV), intended for OBGYN, primary care, and urgent care clinicians.

Quantifiable outcome

• Next-day diagnostic results — faster than leading national labs
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Pro LIMS (HIPAA-compliant Lab Software)coreTechnology or IntegrationPro LIMS is a HIPAA-compliant laboratory information management system integrated into Labtest Bio's workflow. The company offers free EMR/LIS integration with Pro LIMS, enabling streamlined test ordering and resulting for clinical partners. This integration is a core component of the company's value proposition for healthcare providers.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: One of the two dominant U.S. clinical reference laboratory networks, offering extensive molecular infectious disease testing panels and nationwide logistics. Directly comparable as a national molecular reference lab serving the same clinician base, though far larger and broader in scope than Labtest Bio.
• ARUP Laboratories: Academic medical center-affiliated national reference laboratory offering extensive esoteric and molecular infectious disease testing to hospitals and reference clients. Comparable as a reference lab serving complex clinical diagnostics needs, though broader and more hospital-channel-focused than Labtest Bio.
• Laboratory Corporation of America (Labcorp): The other dominant U.S. national reference laboratory, offering PCR/NAAT-based infectious disease panels and routine molecular testing to physicians, hospitals, and SNFs. Operates a nationwide patient service center and logistics network that Labtest Bio's three facilities cannot match in convenience.
• Mayo Clinic Laboratories: Hospital-affiliated national esoteric reference laboratory offering specialty molecular and infectious disease testing globally. Comparable as a reference laboratory serving clinicians with complex diagnostics, though anchored in academic hospital distribution rather than OBGYN/SNF channels.
• BioReference Health (formerly BioReference Laboratories, an OPKO Health subsidiary): A national full-service clinical reference laboratory with a strong footprint in women's health, oncology, and infectious disease molecular diagnostics. Competes for similar OBGYN and specialty clinician customers with broader routine testing capabilities than Labtest Bio's infectious disease-focused menu.

Emerging players

• Molecular Testing Labs: An independently owned molecular reference laboratory offering PCR-based STI, UTI, and women's health panels to clinicians with a similar focus on specialty infectious disease testing. A near-direct comparable in size and customer targeting to Labtest Bio's customizable panel model.

Direct peers

• Viracor Eurofins: A specialty molecular and immunology reference laboratory with a similar focus on complex infectious disease and immune-mediated testing for clinicians. Competes head-to-head in NAAT-based infectious disease panels with a specialty-lab service model analogous to Labtest Bio's customization and rapid turnaround positioning.
• Aegis Sciences Corporation: A specialty reference laboratory offering molecular infectious disease, toxicology, and pharmacogenomic testing with rapid turnaround to clinicians. Closely comparable mid-size specialty molecular lab competing for similar OBGYN, urgent care, and pain/ID physician relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/ProLabDirectUSA
• LinkedInlinkedin.com/company/labtest-bio
• Instagraminstagram.com/labtest.bio

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about labtest.bio